TFA
ACET icon

Toth Financial Advisory’s Adicet Bio ACET Stock Holding History

Toth Financial Advisory’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$1.3K – 920
2025
Q3 		$1.3K Hold
100
– – ﹤0.01% 732
2025
Q2 		$976 Buy
+100
New +$1.05K ﹤0.01% 700

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Toth Financial Advisory's ACET Position: Q4 2025 in Review

Toth Financial Advisory sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 100 shares — an estimated $1.3K sold.

Toth Financial Advisory first reported a position in ACET in Q2 2025 and held it in 2 quarters. The position peaked at $1.3K in Q3 2025. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Toth Financial Advisory reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Toth Financial Advisory sold 100 Adicet Bio shares in Q4 2025, an estimated $1.3K.
  • Toth Financial Advisory first reported a position in Adicet Bio in Q2 2025 and held it in 2 quarters.
  • Toth Financial Advisory's Adicet Bio position peaked at $1.3K in Q3 2025.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Toth Financial Advisory's 13F filing for Q4 2025, filed 20 Jan 2026.